Nuvaring and Eye inflammation - a phase IV clinical study of FDA data

Summary:

Eye inflammation is reported as a side effect among people who take Nuvaring (ethinyl estradiol; etonogestrel), especially for people who are female, 40-49 old, also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Eye inflammation when taking Nuvaring. It is created by eHealthMe based on reports of 27,664 people who have side effects when taking Nuvaring from the FDA, and is updated regularly.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.

What is Eye inflammation?

Eye inflammation is found to be associated with 564 drugs and 581 conditions by eHealthMe. Check the latest studies of Eye inflammation.

On Aug, 04, 2026

27,664 people reported to have side effects when taking Nuvaring.
Among them, 17 people (0.06%) have Eye inflammation.

Among these 17 people:

What is the gender of people who have Eye inflammation when taking Nuvaring? *

female: 100 %
male: 0.0 %

What is the age of people who have Eye inflammation when taking Nuvaring? *

What are other drugs people take besides Nuvaring? *

Celebrex: 17 people, 100.00%
Actemra: 17 people, 100.00%
Hctz: 11 people, 64.71%
Methotrexate: 6 people, 35.29%
Hydrochlorothiazide: 6 people, 35.29%

What are other side effects people have besides Eye inflammation? *

Weight Increased: 17 people, 100.00%
Joint Pain: 17 people, 100.00%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 17 people, 100.00%
Gallstones (stone formation by bile component): 17 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 100.00%
High Blood Pressure: 17 people, 100.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 17 people, 100.00%
Kidney Stones: 17 people, 100.00%
Urinary Tract Infection: 17 people, 100.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 94.12%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvaring and have Eye inflammation?

- Check whether Eye inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nuvaring:

Nuvaring (28,730 reports)

Eye inflammation treatments and more:

Eye inflammation (10,948 reports)

How severe was Eye inflammation and when was it recovered:

Eye inflammation in Nuvaring

Expand to all the drugs that have ingredients of ethinyl estradiol; etonogestrel:

Eye inflammation and drugs with ingredients of ethinyl estradiol; etonogestrel

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye inflammation:

Eye inflammation (564 drugs)

Browse all the conditions that are associated with Eye inflammation:

Eye inflammation (581 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; etonogestrel (the active ingredients of Nuvaring) and Nuvaring (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.